Overview of Challenges With Using Cost-Effectiveness Analysis for Evaluating Medications [0.03%]
成本效益分析在药品评估中应用的挑战综述
Christopher J Edwards,Brian L Erstad
Christopher J Edwards
Countries such as Australia with universal healthcare perform cost-effectiveness evaluations of new prescription medications. In the United States, there is no assessment of cost-effectiveness analysis at the national level with the notable...
Nicholas W Carris,Shawn Wallace,Marilyn Stern et al.
Nicholas W Carris et al.
Clinical Outcomes of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) and Glucagon-Like Peptide-1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (GLP-1/GIP RA) Exposures Presenting to the Emergency Department [0.03%]
急诊科就诊的胰高血糖素样肽-1受体激动剂（GLP-1RA）和胰高血糖素样肽-1/葡萄糖依赖性促胰岛素多肽受体激动剂（GLP-1/GIP RA）暴露的临床结局
Hayley T Gartner,Reeves E Simmons,Herbert Z Wan et al.
Hayley T Gartner et al.
Background: Glucagon-like peptide-1 receptor agonist (GLP-1 RA) and glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist (GLP-1/GIP RA) use has become increasingly popular, leading to a ri...
Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19 [0.03%]
瑞德西韦对住院成人COVID-19患者心率和心动过缓的影响
Wesley D Kufel,Zoey J Zagoria,Robert W Seabury et al.
Wesley D Kufel et al.
Background: Bradycardia is not currently described as an adverse effect in prescribing information for remdesivir but has been reported postapproval. Therefore, effects on heart rate (HR) and bradycardia incidence after r...
Bradley Phillips,Cierra Abbott,Savanna Breit et al.
Bradley Phillips et al.
Objective: This review aims to evaluate the efficacy and safety of olezarsen (Tryngolza) in treating familial chylomicronemia syndrome (FCS), a rare genetic disorder characterized by severe hypertriglyceridemia. ...
Comment on "Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Nervous System Disorders: A Systematic Review and Meta-Analysis" [0.03%]
关于《钠-葡萄糖共转运蛋白2抑制剂对神经系统疾病的效应：系统性回顾和荟萃分析》的评论
Rachana Mehta,Shubham Kumar,Ranjana Sah
Rachana Mehta
Association Between Rocuronium Administration and Clinical Outcomes in Patients With Moderate-To-Severe Acute Respiratory Distress Syndrome: A Retrospective Cohort Study [0.03%]
罗库溴铵的使用与中重度急性呼吸窘迫综合征患者临床结局之间的关系：一项回顾性队列研究
Mayuko Tonai,Yusuke Sasabuchi,Hideaki Watanabe et al.
Mayuko Tonai et al.
Background: Neuromuscular blocking agents (NMBAs) are commonly used to manage acute respiratory distress syndrome (ARDS). However, the efficacy of continuous NMBA administration other than cisatracurium remains understudi...
Xanomeline-Trospium: A Novel Therapeutic for the Treatment of Schizophrenia [0.03%]
Xanomeline-Trospium：一种新型的精神分裂症治疗药物
Olivia L Ramey,Armando Silva Almodóvar
Olivia L Ramey
Objective: This review describes a novel combination muscarinic agonist and antagonist, xanomeline-trospium, which was recently approved by the Food and Drug Administration (FDA) for schizophrenia. Efficacy and safety evi...
Comparison of Error Incidence Between Single-Tablet Versus Multiple-Tablet INSTI-Based Regimens in the Inpatient Setting [0.03%]
住院患者INSTI为基础的单片剂与多片剂方案的错误发生率比较
Denise Kelley,Kayla Blackmon,Brian L Nguyen et al.
Denise Kelley et al.
Background: Errors related to antiretroviral therapy (ART) occur in up to 86% of hospitalized patients living with human immunodeficiency virus (HIV) and may contribute to treatment failure, drug resistance, adverse effec...